↓ Skip to main content

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)

Overview of attention for article published in BMC Infectious Diseases, December 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)
Published in
BMC Infectious Diseases, December 2018
DOI 10.1186/s12879-018-3562-2
Authors

Thijs ten Doesschate, Suzan P. van Mens, Cees van Nieuwkoop, Suzanne E. Geerlings, Andy I. M. Hoepelman, Marc J. M. Bonten

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 71 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 15%
Student > Bachelor 8 11%
Other 7 10%
Researcher 6 8%
Student > Ph. D. Student 5 7%
Other 18 25%
Unknown 16 23%
Readers by discipline Count As %
Medicine and Dentistry 24 34%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Nursing and Health Professions 4 6%
Unspecified 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 11 15%
Unknown 21 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2018.
All research outputs
#6,615,150
of 22,440,112 outputs
Outputs from BMC Infectious Diseases
#2,034
of 7,549 outputs
Outputs of similar age
#150,366
of 429,880 outputs
Outputs of similar age from BMC Infectious Diseases
#155
of 603 outputs
Altmetric has tracked 22,440,112 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 7,549 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,880 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 603 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.